Home Business Life Science

Subscribe Now

Life Science

Artios Pharma’s DNA damage response collaboration with Novartis worth a potential $1.3bn

It will receive $20m upfront.

Winners of Cambridge Independent Science and Technology Awards revealed

Fourteen categories celebrated extraordinary talent, from biotech to AI.

Biofidelity lines up first product after being granted key patent in US protect its cancer diagnosis technology

The company has won Start-up of the Year at the Cambridge Independent Science and Technology Awards.

Stage is set for Cambridge Independent Science and Technology Awards

A limited number of tickets are now on sale.

Eliem Therapeutics is out of stealth mode and $80m in the black

Biotech’s targets include chronic pain, depression, epilepsy and anxiety

Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients

CEO Sarah Howell is nominated as CEO of the Year at the Cambridge Independent Science and Technology Awards.

Epigenetics expert Prof Wolf Reik appointed director of the Babraham Institute

He has been acting director since the death of Prof Michael Wakelam.

Precision medicine combination to be offered to more ovarian cancer patients

Olaparib - discovered by Prof Steve Jackson’s team at the University of Cambridge - is available with bevacizumab under the Cancer Drugs Fund.

Cambridge Consultants develops core technology for Ellume’s world-first fully-at-home over-the-counter Covid-19 test

The US government has struck a $231.8m deal for the delivery of 8.5 million tests.

Abcam reports revenue growth in spite of restrictions facing half the world’s labs

The Cambridge-based life science research tools provider said demand has yet to return to normal.

Demand for lab space in Cambridge region at five-year high, says Bidwells

Its report says take-up of office and lab space returned to trend levels in the second half of 2020.

Cambridge Festival launches programme of events

The lineup for the inaugural online Cambridge Festival has gone live.

Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge

They will get seed funding, access to facilities and lab space.

AstraZeneca posts stellar full-year results for 2020 powered by new medicines

Revenues rose 10 per cent to $26.62billion.

Cambridge company supports trial to keep over-65s with Covid-19 out of hospital

ReCoVa-19 is aiding recruitment through its testing programme.

Blood test for minimal residual disease in cancer patients will be accelerated by $35m Inivata financing

It raises Series C financing to $60m

Sano Genetics to accelerate long Covid research after £2.5m seed funding

The Cambridge-based digital health technology company will supply at-home DNA testing kits for 3,000 patients.

Astex and Taiho strike further oncology licensing deal with MSD

It focuses on small molecule SHP2 inhibitor candidates.

Sanofi to acquire Babraham Research Campus-based Kymab in deal worth up to $1.45bn

The deal is expected to be completed in the first half of 2021.

Light Blue Fibre’s full-fibre network enables high-performance computing in Cambridge region

It is designed to handle the massive data demands for the life science industry and explosion in artificial intelligence.

Sosei Heptares to regain rights from AbbVie to programmes targeting neurological diseases

They were initially licensed to Allergan.

Life Science

Artios Pharma’s DNA damage response collaboration with Novartis worth a potential $1.3bn

Winners of Cambridge Independent Science and Technology Awards revealed

Winners of Cambridge Independent Science and Technology Awards revealed

Biofidelity lines up first product after being granted key patent in US protect its cancer diagnosis technology

Biofidelity lines up first product after being granted key patent in US protect its cancer diagnosis technology

Stage is set for Cambridge Independent Science and Technology Awards

Stage is set for Cambridge Independent Science and Technology Awards

Eliem Therapeutics is out of stealth mode and $80m in the black

Eliem Therapeutics is out of stealth mode and $80m in the black

Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients

Arecor awarded £2.8m to progress insulin product that could enable artificial pancreas system for type I diabetes patients

Epigenetics expert Prof Wolf Reik appointed director of the Babraham Institute

Epigenetics expert Prof Wolf Reik appointed director of the Babraham Institute

Precision medicine combination to be offered to more ovarian cancer patients

Precision medicine combination to be offered to more ovarian cancer patients

Cambridge Consultants develops core technology for Ellume’s world-first fully-at-home over-the-counter Covid-19 test

Cambridge Consultants develops core technology for Ellume’s world-first fully-at-home over-the-counter Covid-19 test

Abcam reports revenue growth in spite of restrictions facing half the world’s labs

Abcam reports revenue growth in spite of restrictions facing half the world’s labs

Demand for lab space in Cambridge region at five-year high, says Bidwells

Demand for lab space in Cambridge region at five-year high, says Bidwells

Cambridge Festival launches programme of events

Cambridge Festival launches programme of events

Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge

Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge

AstraZeneca posts stellar full-year results for 2020 powered by new medicines

AstraZeneca posts stellar full-year results for 2020 powered by new medicines

Cambridge company supports trial to keep over-65s with Covid-19 out of hospital

Cambridge company supports trial to keep over-65s with Covid-19 out of hospital

Blood test for minimal residual disease in cancer patients will be accelerated by $35m Inivata financing

Blood test for minimal residual disease in cancer patients will be accelerated by $35m Inivata financing

Sano Genetics to accelerate long Covid research after £2.5m seed funding

Sano Genetics to accelerate long Covid research after £2.5m seed funding

Astex and Taiho strike further oncology licensing deal with MSD

Astex and Taiho strike further oncology licensing deal with MSD

Sanofi to acquire Babraham Research Campus-based Kymab in deal worth up to $1.45bn

Sanofi to acquire Babraham Research Campus-based Kymab in deal worth up to $1.45bn

Light Blue Fibre’s full-fibre network enables high-performance computing in Cambridge region

Light Blue Fibre’s full-fibre network enables high-performance computing in Cambridge region

Sosei Heptares to regain rights from AbbVie to programmes targeting neurological diseases

Sosei Heptares to regain rights from AbbVie to programmes targeting neurological diseases

MOST READ